Plasma Hyaluronan Levels in Rabbit Immobilization Osteoarthritis: Effect of Remobilization

References

• Langenskiold A, Michelsson J-E, Videman T. Osteoarthritis of the knee in the rabbit produced by immobilization. Attempts to achieve a reproducible model for studies on pathogenesis and therapy. Acta Orthop Scand 1979; 50: 1–14
   PubMed Web of Science ®Google Scholar
• Videman T, Michelsson J-E, Langenskiöld A. The development of radiographic changes in experimental osteoarthritis provoked by immobilization of the knee in rabbits. IRCS J Med Sci 1977; 5: 62–6
   Google Scholar
• Troyer H. Experimental models of osteoarthritis: a review. Semin Arthritis Rheum 1982; 11: 362–74
   PubMedGoogle Scholar
• Michelsson J-E, Hunneyball IM. Inflammatory involvement in rabbit knee following immobilization and resulting in osteoarthritis. Scand J Rheumatol 1984; 13: 273–81
   PubMed Web of Science ®Google Scholar
• Konttinen Y T, Michelsson J-E, Tolvanen E, Bergroth V. Primary inflammatory reaction in synovial fluid and tissue in rabbit immobilization osteoarthritis. Clin Orthop 1990; 260: 280–6
   Google Scholar
• Engström-Laurent A, Hällgren R. Circulating hyaluronic acid levels vary with physical activity in healthy subjects and in rheumatoid arthritis patients. Relationship to synovitis mass and morning stiffness. Arthritis Rheum 1987; 30: 1333–8
   PubMed Web of Science ®Google Scholar
• Lindqvist U, Engström-Laurent A, Laurent U, Nyberg A, Björklund U, Eriksson H, Pettersson R, Tengblad A. The diurnal variation of serum hyaluronan in health and disease. Scand J Clin Lab Invest 1988; 48: 765–70
   PubMed Web of Science ®Google Scholar
• Saari H, Konttinen Y T, Nordström D. Diurnal profile of serum hyaluronate. Ann Med, in press
   Google Scholar
• Hiro D, Ito A, Matsuta K, Mori Y. Hyaluronic acid is an endogenous inducer of interleukin-1 production by human monocytes and rabbit macrophages. Biochem Biophys Res Commun 1986; 140: 715–22
   PubMed Web of Science ®Google Scholar
• Postlethwaite A E, Lachman L B, Kang AH. Stimulation of fibroblast hyaluronic acid production by human interleukin 1 (abstract). Arthritis Rheum 1983; 26: S59, Suppl
   Google Scholar
• Hammerman D, Wood DD. Interleukin-1 enhances synovial cell hyaluronate synthesis. Proc Soc Exp Biol Med 1984; 177: 205–10
   PubMedGoogle Scholar
• Bocquet J, Langris M, Daireaux V, Jouis V, Pujol J P, Beliard R, Loyau G. Mononuclear cell mediated modulation of synovial cell metabolism. II. Increased hyaluronic acid synthesis by a monocyte cell factor (MCF). Exp Cell Res 1985; 160: 9–18
   PubMed Web of Science ®Google Scholar
• Postlethwaite A E, Kang AH. Stimulation of fibroblast hyaluronic acid by recombinant murine interleukin-1 (abstract). Clin Res 1986; 34: 221A
   Google Scholar
• Yaron I, Meyer F A, Dayer J-M, Yaron M. Human recombinant interleukin-1 stimulates glycosaminoglycan production in human synovial fibroblast cultures. Arthritis Rheum 1987; 30: 424–30
   PubMedGoogle Scholar
• Butler D M, Vitti G F, Leizer T, Hamilton JA. Stimulation of the hyaluronic acid levels of human synovial fibroblasts by recombinant tumor necrosis factor χ, tumor necrosis factor β (lymphotoxin), interleukin-1χ, and interleukin-1β. Arthritis Rheum 1988; 31: 1281–9
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Interleukin-1 and its biologically related cytokines. Adv Immunol 1989; 44: 153–205
   PubMed Web of Science ®Google Scholar
• Dingle JT. Catabolin - a cartilage catabolic factor from synovium. Clin Orthop 1981; 156: 219–31
   PubMed Web of Science ®Google Scholar
• Brandt R, Hedlöf E, Åsman I, Bucht A, Tengblad A. A convenient radiometric assay for hyaluronate. Acta Otolaryngol Suppl 1987; 442: 31–5
   PubMedGoogle Scholar
• O'Brien P C, Shampo MA. Statistical considerations for performing multiple tests in a single experiment. 3. Repeated measures over time. Mayo Clin Proc 1988; 63: 918–20
   PubMed Web of Science ®Google Scholar
• Hamerman D. Osteoarthritis. Orthop Rev 1988; 17: 353–60
   PubMedGoogle Scholar
• Moskowitz RW. Primary osteoarthritis: epidemiology, clinical aspects, and general management. Am J Med 1987; 83: 5–10
   PubMed Web of Science ®Google Scholar
• Lloyd-Roberts GC. The role of capsular changes in osteoarthritis of the hip joint. J Bone Joint Surg (Br) 1953; 35-B: 627–42
   PubMedGoogle Scholar
• Pringle J A, Byers P D, Brown M EA. Immunofluorescence in osteoarthritis. Nature 1978; 274: 94
   PubMedGoogle Scholar
• Arnoldi C C, Reiman I, Bretlay P. The synovial membrane in human coxarthrosis. Light and electron microscope studies. Clin Orthop 1979; 148: 213–20
   Google Scholar
• Goldenberg D L, Egan M S, Cohen AS. Inflammatory synovitis in degenerative joint disease. J Rheumatol 1982; 9: 204–9
   PubMed Web of Science ®Google Scholar
• Johnell O, Hulth A, Henricson A. T-lymphocyte subsets and HLA-DR-expressing cells in the osteoarthritic synovialis. Scand J Rheumatol 1985; 14: 259–64
   PubMed Web of Science ®Google Scholar
• Konttinen Y T, Saari H, Santavirta S, Antti-Poika I, Sorsa T, Nykänen P, Kemppinen P. Synovial fibroblasts. Scand J Rheumatol 1988; 76: 95–103, Suppl
   Google Scholar
• Tulamo R-M, Saari H, Konttinen YT. Concentration of hyaluronate in equine serum. Am J Vet Res 1990; 51: 740–2
   PubMed Web of Science ®Google Scholar
• Fraser J RE, Laurent T C, Engström-Laurent A, Laurent U GB. Elimination of hyaluronic acid from the blood stream in the human. Clin Exp Pharmacol 1984; 11: 17–25
   Web of Science ®Google Scholar
• Engström-Laurent A, Laurent U B, Lilja K, Laurent TC. Concentration of sodium hyaluronate in serum. Scand J Clin Lab Invest 1985; 45: 497–504
   PubMed Web of Science ®Google Scholar
• Cohen A S, Goldenberg D. Synovial fluid. Laboratory diagnostic procedures in the rheumatic diseases., 3rd edn, AS Cohen. Grune and Stratton, Orlando 1985; 1–54
   Google Scholar
• Saari H, Konttinen YT. Determination of synovial fluid hyaluronate concentration and polymerization by high performance liquid chromatography. Ann Rheum Dis 1989; 48: 565–570
   PubMedGoogle Scholar
• Konttinen Y T, Saari H, Honkanen V, Szocsik K, Mussalo-Rauhamaa H, Friman C. Serum baseline hyaluronate and disease activity in rheumatoid arthritis. Clin Chim Acta 1991; 193: 39–47
   Google Scholar